Processa Pharmaceuticals's total assets for Q3 2025 were $7.58M, a decrease of -7.30% from the previous quarter. PCSA total liabilities were $1.75M for the fiscal quarter, a -15.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.